Phibro Animal Health Corporation

NASDAQ:PAHC

Drug Manufacturers - Specialty & Generic

Healthcare
$35.57 +1.23%

+$0.38 today

Market cap
$1.44B
Beta
0.46
P/E (TTM)
13.3
EPS (TTM)
$2.35
Dividend yield
1.54%
52W Low $23.57High $60.08

Volume 0.11M

Average 0.37M

PAHC Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Phibro Animal Health CorporationNASDAQ: PAHC

Net Receivables · Q3 FY2026 · quarter ended Mar 2026

Net receivables rises 12.2% from a year ago

Net receivables stood at $221.55M at the end of Q3 FY2026, up 12.2% from a year earlier and up 2.6% from the prior quarter. Over 3 fiscal years it compounded at +11.0% a year.

Context

  • Net receivables amounted to 15.3% of total assets at the end of Q3 FY2026, up 0.3 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +12.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$221.55M+2.6% QoQ
Last fiscal yearJun 2025
$227.98M+34.5% YoY
Year agoMar 2025
$197.52M+12.2% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+12.2%——
1 year+34.5%——
3-year CAGR+11.0%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
227.98M USD
Year-over-year change
+34.5%
4-year CAGR
+11.6%

Net Receivables vs competitors

How PAHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +12.2% is the highest of 6, against a peer median of +2.0%.
  • Net receivables amounts to 15.3% of total assets for PAHC, versus a peer median of 8.0%.
PAHC Competitors
Net Receivables for PAHC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRKMerck & Co., Inc.Jun 2026$12.56B USD+6.1%+10.3%9.7%
ZTSZoetis Inc.Jun 2026$1.57B USD+2.0%+9.4%10.4%
ELANElanco Animal Health IncorporatedSep 2026$1.06B USD+9.0%-2.1%8.0%
PAHCPhibro Animal Health CorporationMar 2026$221.55M USD+12.2%+11.0%15.3%
NEOGNeogen CorporationAug 2026$136.2M USD-1.6%-1.4%4.1%
ZYBTZhengye Biotechnology Holding LimitedDec 2025CN¥18.49M CNY-79.1%-48.4%4.2%
Peer median (excluding PAHC) —+2.0%-1.4%8.0%

Competitors are the stored peer set for PAHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents50.21M74.25M41.28M70.61M68.04M
Short-term Investments43M17M40M44M9M
Net Receivables146.85M166.54M163.48M169.45M227.98M
Inventory216.31M259.16M277.57M265.91M444.43M
Other Current Assets42.53M49.29M63.39M51.02M61.16M
Total Current Assets498.91M566.23M585.72M601M810.61M
Property, Plant & Equipment (Net)187.67M203.17M231.33M240.9M396.03M
Goodwill52.68M53.23M53.27M54.56M59.65M
Intangible Assets62.28M63.86M54.99M45.03M36.47M
Long-term Investments10.11M10.35M11.09M11.49M11.69M
Tax Assets9.86M5.85M8.71M19.37M25.55M
Other Non-current Assets19.82M29.02M26.28M9.83M20.91M
Total Non-current Assets342.42M365.47M385.67M381.19M550.29M
Total Assets841.33M931.7M971.4M982.18M1.36B
Account Payables68.36M95.6M73.85M85.57M138.2M
Short-term Debt9.38M15M22.3M29.8M16.25M
Tax Payables6.11M7.21M8.66M2.93M8.4M
Deferred Revenue00000
Other Current Liabilities56.21M53.18M48.22M55.15M83M
Total Current Liabilities164.12M190.83M176M204.15M293.47M
Long-term Debt382.71M417.93M452.54M458.29M702.44M
Deferred Tax Liabilities6.65M9.26M12.15M14.22M19.47M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities21.32M19.73M19.12M18.97M26.1M
Total Non-current Liabilities438.68M478.43M512.89M521.4M781.75M
Total Liabilities602.8M669.26M688.89M725.54M1.08B
Common Stock4K4K4K4K4K
Retained Earnings218.02M247.75M260.91M243.89M272.7M
Accumulated OCI(115.29M)(121.11M)(114.21M)(123.53M)(124.02M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity238.53M262.44M282.51M256.64M285.68M
Total Debt426.71M470.48M509.97M525.46M761.55M
Net Debt376.49M396.24M468.69M454.85M693.51M

Phibro Animal Health Corporation

NASDAQ:PAHC

Intrinsic Alpha fair value

Locked

Current Price

$35.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.